DTIL
DTIL
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
3
$30K
Insider Sales
0
$0
Total Volume
$30K
3 transactions
Net Activity
+$30K
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Germano Geno J
Dir
$16K total
Brown Melinda
Dir
$7K total
Frankel Stanley
Dir
$6K total
Quick Actions
DTIL has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at DTIL (DTIL) engaged in a total of 3 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 0 were sales. The total volume of insider trading reached $30K.
The net insider activity for DTIL shows a net buying bias of $30K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Germano Geno J (Dir), who traded 2.6K shares valued at $16K on Sep 25, 2026.
Precision Biosciences Stock Price Forecast. Should You Buy DTIL?
DTIL Forecast — Price Target — Prediction for 2027
Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?
Precision BioSciences (DTIL) Stock Stalls After Q3 Earnings Loss Narrows
A study testing gene editing for Duchenne muscular dystrophy has given its first patient a dose.
symbol__ Stock Quote Price and Forecast
FAQs About DTIL Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for DTIL.